| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |